Haemonetics HAE Business Segments
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Net revenues by Business | |||||
| Blood Center | $221.27M-15.3% | $261.12M— | —— | —— | |
| Hospital | $588.3M+4.3% | $564.27M— | —— | —— | |
| Plasma | $524.46M-2.0% | $535.43M— | —— | —— | |
| Total net revenues by Product | |||||
| Plasma | $524.46M-2.0% | $535.43M-6.0% | $569.54M+10.4% | $515.89M+46.8% | |
| Net revenues by Geography | |||||
| Europe | $185.02M+5.3% | $175.66M+9.7% | $160.14M+2.2% | $156.68M-4.2% | |
| Japan | $68.2M+9.3% | $62.41M+7.4% | $58.09M-5.2% | $61.3M-18.9% | |
| Other | $11.42M-41.5% | $19.54M+47.1% | $13.28M+264% | $3.65M-8.4% | |
| Rest of Asia | $87.21M-5.5% | $92.31M-14.2% | $107.54M+3.3% | $104.14M-6.0% | |
| United States | $982.18M-2.8% | $1.01B+4.2% | $970.01M+15.1% | $842.9M+31.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 3 parts — Blood Center, Hospital and Plasma. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.